These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 16474301

  • 1. [The use of pentoxyphylline in the treatment of patients with chronic obliterative diseases of lower limb arteries].
    Koshkin VM.
    Angiol Sosud Khir; 2005; 11(4):141-7. PubMed ID: 16474301
    [Abstract] [Full Text] [Related]

  • 2. [Experience with pentoxifylline in chronic obliterative disease of the leg arteries in hospitalized and ambulatory patients].
    Sondern W, Leube G.
    Med Welt; 1979 Sep 14; 30(37):1367-9. PubMed ID: 502814
    [No Abstract] [Full Text] [Related]

  • 3. Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter study.
    Trübestein G, von Bary S, Breddin K, Diehm C, Gruss JD, Heinrich H, Horsch S, Kriessmann A, Maass U, Martin M.
    Vasa Suppl; 1989 Sep 14; 28():44-9. PubMed ID: 2692200
    [Abstract] [Full Text] [Related]

  • 4. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May 23; 144(21):54. PubMed ID: 12134429
    [No Abstract] [Full Text] [Related]

  • 5. Intravenous oxypentifylline in critical limb ischaemia.
    Galvin KT, Gorst KL, Primrose JN, Kester RC.
    Br J Clin Pract; 1989 May 23; 43(5):169-72. PubMed ID: 2686747
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries.
    Diehm N, Baumgartner I, Jaff M, Do DD, Minar E, Schmidli J, Diehm C, Biamino G, Vermassen F, Scheinert D, van Sambeek MR, Schillinger M.
    Eur Heart J; 2007 Apr 23; 28(7):798-805. PubMed ID: 17317699
    [Abstract] [Full Text] [Related]

  • 10. [Clinical and hemodynamic evaluation of the action of pentoxifylline in patients with obstructive arteriopathy of the lower extremities].
    Zaccaria A, Antonini M, Marciani A, Taurino M, Speziale F, Spartera C.
    Ric Clin Lab; 1981 Apr 23; 11 Suppl 1():381-6. PubMed ID: 7188126
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease.
    Miyazaki M, Higashi Y, Goto C, Chayama K, Yoshizumi M, Sanada H, Orihashi K, Sueda T.
    J Cardiovasc Pharmacol; 2007 Apr 23; 49(4):221-7. PubMed ID: 17438407
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Even when walking yet does not cause any pain, peripheral arterial occlusive disease costs life years].
    MMW Fortschr Med; 2003 Apr 10; 145(15):63. PubMed ID: 15104272
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Ticlid: clinical effectiveness and significance in combined conservative treatment of chronic obliterating diseases of lower limb arteries].
    Koskin VM, Bogdanets LI.
    Ter Arkh; 1998 Apr 10; 70(9):89-91. PubMed ID: 9821239
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.